| Literature DB >> 26228763 |
Paolo Ricchi1, Antonella Meloni2,3, Anna Spasiano1, Maria Giovanna Neri2, Maria Rita Gamberini4, Liana Cuccia5, Vincenzo Caruso6, Calogera Gerardi7, Domenico Giuseppe D'Ascola8, Rosamaria Rosso9, Saveria Campisi10, Michele Rizzo11, Fabrizia Terrazzino12, Alessandra Briatico Vangosa13, Elisabetta Chiodi14, Massimiliano Missere15, Maurizio Mangione16, Vincenzo Positano2,3, Alessia Pepe2.
Abstract
The aim of this study was to evaluate, in a large cohort of chronically transfused patients, whether the presence of extramedullary hematopoiesis (EMH) accounts for the typical patterns of cardiac iron distribution and/or cardiac function parameters. We retrospectively selected 1,266 thalassemia major patients who had undergone regular transfusions (611 men and 655 women; mean age: 31.3 ± 8.9 years, range: 4.2-66.6 years) and were consecutively enrolled within the Myocardial Iron Overload in Thalassemia network. The presence of EMH was evaluated based on steady-state free precession sequences; cardiac and liver iron overloads were quantified using a multiecho T2* approach; cardiac function parameters and pulmonary diameter were quantified using the steady-state free precession sequences; and myocardial fibrosis was evaluated using the late gadolinium enhancement technique. EMH was detected in 167 (13.2%) patients. The EMH+ patients had significantly lower cardiac iron overload than that of the EMH- patients (P = 0.003). The patterns of cardiac iron distribution were significantly different in the EMH+ and EMH- patients (P < 0.0001), with a higher prevalence of patients with no myocardial iron overload and heterogeneous myocardial iron overload and no significant global heart iron in the EMH+ group EMH+ patients had a significantly higher left ventricle mass index (P = 0.001) and a significantly higher pulmonary artery diameter (P = 0.002). In conclusion, in regularly transfused thalassemia patients, EMH was common and was associated with a thalassemia intermedia-like pattern of cardiac iron deposition despite regular transfusion therapy.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26228763 DOI: 10.1002/ajh.24139
Source DB: PubMed Journal: Am J Hematol ISSN: 0361-8609 Impact factor: 10.047